BOSTON and LAUSANNE, Switzerland, Feb. 4, 2025 /PRNewswire/ -- Alys Pharmaceuticals, Inc. ("Alys"), an immune-dermatology focused company, today announces that the U.S. Food and Drug ...
Alvotech and Teva announced that the Food and Drug Administration has accepted for review Biologics License Applications for AVT05, Alvotech’s proposed biosimilar to Simponi and Simponi Aria ...
After hours: February 7 at 4:01:37 PM EST Loading Chart for ALVO ...
After hours: 7:38:15 p.m. EST ...
After hours: 7:59:46 pm GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback